Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Eve Investments.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Weed Week: The great German bake-off
News
Rise & Shine: What you need to know before the ASX opens
News
Rise & Shine: What you need to know before the ASX opens
News
Weed Week: US looks at ways to help cannabis players get banking access
Health & Biotech
The Pot Seat distilled: The 9 key things we know now about Aussie cannabis
News
Weekly ASX small cap wrap: Who’s been batting 100 this week?
Health & Biotech
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Health & Biotech
The Pot Seat: Eve’s Ben Rohr says cannabis honey could be a thing in 2021
News
Weed Week: Will Australia fear to tread where NZ steps with cannabis legalisation?
Food & Agriculture
Cannabis: THC is allowed to export, but still no sign of one crucial licence
Health & Biotech
These six Aussie pot stocks raised 70pc of cannabis capital in 2018
Health & Biotech
Cannabis investor EVE gains 12pc after finalising lease of pot site to Hydroponics Co
Health & Biotech
Eve buys a tea tree farm, solidifies position as cannabis purveyor
Health & Biotech
THC’s got a new pot plot – but it’s still waiting on a growing licence
Health & Biotech
Here’s how much money ASX cannabis stocks made last quarter
Health & Biotech